Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase

• Published in: Thrombosis and haemostasis Vol. 89; no. 6; p. 1016
• Main Authors: Libersan, Danielle, Merhi, Yahye
• Format: Journal Article
• Language: English
• Published: Germany 01.06.2003
• Subjects: Blood Platelets - metabolism; Blood Platelets - ultrastructure; Humans; Isoenzymes - physiology; P-Selectin - analysis; P-Selectin - biosynthesis; Phosphatidylinositol 3-Kinases; Protein Kinase C - physiology; Protein-Tyrosine Kinases; Secretory Vesicles - secretion; Signal Transduction; Thrombin
• ISSN: 0340-6245
• DOI: 10.1055/s-0037-1613403

P-selectin is translocated from the alpha-granules to the surface of activated platelets where it participates in thrombosis and inflammation. We investigated the signaling pathways involved in thrombin-induced human platelet P-selectin expression. Assessed by flow cytometry, inhibition of protein kinase C (PKC) with chelerythrine reduced P-selectin expression by 66%, platelet/neutrophil binding, GPIIb/IIIa activation and aggregation (p<0.05). Gö 6976, an inhibitor of the conventional PKCs (alpha and beta), did not alter P-selectin expression. However, rottlerin inhibited by 50% its expression (p<0.05), but only at doses that interfere with the novel (epsilon eta) and atypical (zeta) PKCs. Inhibition of protein tyrosine kinase (PTK) and phosphoinosi-tide 3-kinase (PI3-K) did not significantly affect P-selectin expression. In conclusion, thrombin-induced P-selectin expression is PKC-sensitive, but PTK and PI3-K-insensitive. The novel epsilon and eta and atypical zeta, but not the conventional alpha and beta and the novel delta PKCs, may be involved in this process.